GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Beneish M-Score

Renata (DHA:RENATA) Beneish M-Score : 0.00 (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Renata Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Renata's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Renata was -1.06. The lowest was -380.40. And the median was -2.49.


Renata Beneish M-Score Historical Data

The historical data trend for Renata's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Beneish M-Score Chart

Renata Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.87 -380.40 -2.74 - -2.40

Renata Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.40 - - -

Competitive Comparison of Renata's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renata's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Renata's Beneish M-Score falls into.



Renata Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Renata for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was BDT4,235 Mil.
Revenue was 9226.168 + 9224.87 + 9440.196 + 8577.961 = BDT36,469 Mil.
Gross Profit was 4184.635 + 4387.366 + 4193.666 + 1451.97 = BDT14,218 Mil.
Total Current Assets was BDT20,819 Mil.
Total Assets was BDT54,357 Mil.
Property, Plant and Equipment(Net PPE) was BDT33,167 Mil.
Depreciation, Depletion and Amortization(DDA) was BDT1,227 Mil.
Selling, General, & Admin. Expense(SGA) was BDT6,800 Mil.
Total Current Liabilities was BDT16,140 Mil.
Long-Term Debt & Capital Lease Obligation was BDT4,260 Mil.
Net Income was 731.379 + 880.827 + 1019.721 + -337.892 = BDT2,294 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = BDT0 Mil.
Cash Flow from Operations was -471.421 + -687.991 + 1009.306 + 2028.293 = BDT1,878 Mil.
Total Receivables was BDT5,321 Mil.
Revenue was 8445.967 + 7576.182 + 8370.646 + 8152.693 = BDT32,545 Mil.
Gross Profit was 3906.261 + 3774.471 + 3953.14 + 3795.759 = BDT15,430 Mil.
Total Current Assets was BDT18,892 Mil.
Total Assets was BDT48,605 Mil.
Property, Plant and Equipment(Net PPE) was BDT29,712 Mil.
Depreciation, Depletion and Amortization(DDA) was BDT1,271 Mil.
Selling, General, & Admin. Expense(SGA) was BDT6,704 Mil.
Total Current Liabilities was BDT15,168 Mil.
Long-Term Debt & Capital Lease Obligation was BDT1,450 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4234.744 / 36469.195) / (5321.294 / 32545.488)
=0.116118 / 0.163503
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(15429.631 / 32545.488) / (14217.637 / 36469.195)
=0.474094 / 0.389853
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (20818.507 + 33166.914) / 54356.736) / (1 - (18892.234 + 29712.283) / 48604.517)
=0.006831 / 0
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=36469.195 / 32545.488
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1271.482 / (1271.482 + 29712.283)) / (1226.73 / (1226.73 + 33166.914))
=0.041037 / 0.035667
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(6800.349 / 36469.195) / (6703.682 / 32545.488)
=0.186468 / 0.205979
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4259.706 + 16139.877) / 54356.736) / ((1449.958 + 15168.46) / 48604.517)
=0.375291 / 0.341911
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(2294.035 - 0 - 1878.187) / 54356.736
=0.00765

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.


Renata (DHA:RENATA) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines